Allergan, Inc.

Allergan Sales, Inc.

Michael W. Grayston

Judith M. Leon

Steven R. Carlson

K. Roger Aoki

Michael W Grayston

Judith M Leon

Steven R Carlson

K Roger Aoki

Kei Roger Aoki

Stephen R Carlson

A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting oftoxin types A, B, C, D, E, F and G.

Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin

A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.

Botulinum toxin treatments

A method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of botulinum toxin types A, B, C, D, E, F and G.

Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle

A method for treating a patient suffering from arthritis and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxic component of neurotoxin selected from a group consisting of Botulinum toxin types A, B, C, D, E, F and G.

Use of the neurotoxic component of a botulinum toxin for treating arthritis

Methods for treating myofascial pain

Methods for treating arthritis pain

A method and composition for treating a patient suffering from an excessive mucus secretion includes administration to the patient of a therapeutically effective amount of a botulinum toxin type A, B, C, D, E, F and/or G.

Method for treating a mucus secretion

Method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of,toxin types A, B, C, D, E, F and G.

Method for treating secretions and glands using botulinum toxin

Use of botulinum toxins for treating various disorders and conditions and associated pain

Method for treating pain with botulinum toxin type B

A method of treating a patient suffering from a disease, disorder or condition includes the administration to the patient of a therapeutically effective amount of botulinum toxin of a selected serotype until the patient experiences loss of clinical response to the administered botulinum toxin and thereafter administering to the patient a therapeutically effective amount of another botulinum toxin of a different serotype.

Growing community of inventors

Irvine, CA, United States of America

Michael W Grayston